FRA:RDC • NL0012044747
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REDCARE PHARMACY NV (RDC.DE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | Berenberg | Maintains | Buy -> Buy |
| 2025-07-17 | Metzler Equities | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.799B 49.35% | 2.371B 31.79% | 2.941B 24.06% | 3.422B 16.36% | 3.846B 12.39% | 4.232B 10.04% | 4.662B 10.16% | 5.212B 11.80% | 6.372B 22.26% | 6.725B 5.54% | |
| EBITDA YoY % growth | 49.669M 455.03% | 29.778M -40.05% | 47.4M 59.18% | 90.515M 90.96% | 134.8M 48.93% | 175.35M 30.08% | 240.62M 37.22% | 258.66M 7.50% | N/A | N/A | |
| EBIT YoY % growth | -7.619M 85.76% | -38.439M -404.52% | -22M 42.77% | 10.46M 147.55% | 49.549M 373.70% | 100.23M 102.28% | 229.94M 129.41% | 265.93M 15.65% | N/A | N/A | |
| Operating Margin | -0.42% | -1.62% | -0.75% | 0.31% | 1.29% | 2.37% | 4.93% | 5.10% | N/A | N/A | |
| EPS YoY % growth | N/A 74.56% | N/A -91.90% | -1.49 22.65% | -0.30 80.18% | 1.43 583.17% | 3.31 131.74% | 6.86 107.47% | 10.28 49.84% | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
16 analysts have analysed RDC.DE and the average price target is 95.46 EUR. This implies a price increase of 96.59% is expected in the next year compared to the current price of 48.56.
REDCARE PHARMACY NV (RDC.DE) will report earnings on 2026-05-06.
The expected long term growth rate for REDCARE PHARMACY NV (RDC.DE) is 12.42%.